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Signal peptide peptidase (SPP) is an unusual aspartyl protease
that mediates clearance of signal peptides by proteolysis within the
endoplasmic reticulum (ER). Like presenilins, which provide the
proteolytically active subunit of the -secretase complex, SPP con-
tains a critical GXGD motif in its C-terminal catalytic center.
AlthoughSPP is known tobe an aspartyl protease of theGXGDtype,
several presenilin homologues/SPP-like proteins (PSHs/SPPL) of
unknown function have been identified by data base searches. We
now investigated the subcellular localization and a putative proteo-
lytic activity of PSHs/SPPLs in cultured cells and in an in vivo
model.We demonstrate that SPPL2b is targeted through the secre-
tory pathway to endosomes/lysosomes, whereas SPP and SPPL3 are
restricted to the ER. As suggested by the differential subcellular
localization of SPPL2b compared with SPP and SPPL3, we found
distinct phenotypes upon antisense gripNA-mediated knockdown
in zebrafish. spp and sppl3 knockdowns in zebrafish result in cell
death within the central nervous system, whereas reduction of
sppl2b expression causes erythrocyte accumulation in an enlarged
caudal vein. Moreover, expression of D/Amutations of the putative
C-terminal active sites of spp, sppl2, and sppl3 produced pheno-
copies of the respective knockdownphenotypes. Thus, our data sug-
gest that all investigated PSHs/SPPLs are members of the novel
family of GXGD aspartyl proteases. Furthermore, SPPL2b is shown
to be the first member of the SPP/PSH/SPPL family that is not
located within the ER but in endosomal/lysosomal vesicles.
Intramembrane proteolysis is mediated by a class of novel polytopic
proteases that have their active centers located within the hydrophobic
transmembrane domains (1, 2).Members of these proteases include the
site-two protease (1), rhomboids (3, 4), -secretase (5), and signal pep-
tide peptidase (SPP)4 (6, 7). Although the site-two protease and rhom-
boids belong to the class of metallo- and serine proteases, respectively,
-secretase and SPP are aspartyl proteases (2, 8, 9). Intramembrane-
cleaving cysteine proteases have so far not been identified. It should,
however, be noted that the precise cleavage sites of the site-two
protease, rhomboids, and SPPs have not yet been directly deter-
mined; thus, it remains possible that cleavage could also occur at or
close to the membrane.
The catalytic core of -secretase is provided by either of the two
homologous presenilins (PS1 or PS2). Co-factors including anterior
pharynx defective 1 (APH-1), presenilin enhancer (PEN)-1, PEN-2, and
Nicastrin are absolutely required to generate a functional -secretase
complex (10–14). PS1- or PS2-containing -secretase complexes can
both mediate the intramembrane cleavage of the -amyloid precursor
protein (APP), Notch, and probably many other type I-oriented sub-
strates as well (8, 15–18), suggesting functional redundancy. Moreover,
several distinct species of APH-1 also appear to be functionally redun-
dant at leastwith respect to-secretase-mediated cleavage of-amyloid
precursor protein fragments (19, 20). However, recent evidence (21)
suggests that -secretase complexes containing different APH-1 species
may have tissue-specific activities. In addition, differential activities of
individual complexes within different subcellular compartments can
also not be excluded.
The C-terminal critical aspartate of PSs is located within a conserved
GXGD motif (22), whereas the N-terminal aspartate is embedded
within a YD sequence segment. The GXGD signature motif is highly
conserved in SPP, an unrelated polytopic aspartyl protease (2, 7, 23, 24),
as well as in the type four prepilin peptidases (22, 25). Moreover,
mutagenesis of the corresponding aspartate residue blocks the proteo-
lytic activity of SPP (7), PS1 (5), PS2 (15, 26), and type four prepilin
peptidases (25). This strongly suggests that the aspartate within the
GXGD motif comprises the C-terminal active site of these proteases.
Furthermore, SPP can also be targeted with highly specific -secretase
inhibitors, demonstrating the similarity of the catalytic centers of SPP
and -secretase (27–29). Further similarities are observed between PSs,
SPP, and type four prepilin peptidases, which also include a PXL motif
within the C-terminal domain. SPP is required for the removal of signal
peptides (2). In addition, SPP is also involved in immune surveillance
and processing of the hepatitis C viral core protein (7), suggesting a
more general role of SPP in the liberation of bioactive peptides (2, 7, 23,
24). Besides SPP, a family of homologous proteins was identified by data
base searches (2, 7, 23, 30, 31). These proteins were named SPPL (SPP-
like) 2 (a, b, c) and 3 (in yeast an additional SPPL, SPPL4, exists) (7) or PS
homologues 1–5 (30). For clarity, we will use the term SPPL throughout
this manuscript. Although SPPLs share some homology with SPPs, it is
not known if they exhibit any proteolytic activity (24).
We now investigated the subcellular distribution and catalytic func-
tion of SPP and SPPLs in human cells and in zebrafish and suggest that
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SPPLs are novel members of the family of aspartyl proteases of the
GXGD type. Moreover, by demonstrating an endosomal/lysosomal
localization of SPPL2b, we provide first evidence that the function of
these proteases may not be necessarily restricted to the ER and the
removal of signal peptides within the early secretory pathway.
EXPERIMENTAL PROCEDURES
Cell Culture, cDNAs, and Transfection—HEK293 cells were cultured
in Dulbecco’s modified Eagle’s medium with Glutamax (Invitrogen)
supplemented with 10% fetal calf serum (Invitrogen). SPP, SPPL2b, and
SPPL3 cDNAs were amplified by PCR from a human brain cDNA







SPP and SPPL3 were subcloned into the pcDNA4/TO/Myc-His vec-
tor and transfected into HEK293 TR cells (Invitrogen). SPPL2b was
subcloned into pcDNA4/Myc-His (Invitrogen) and transfected into a
HEK293 cell line stably overexpressing APP 695 containing the Swedish
mutation (32, 33). Transfection of cells was carried out using Lipo-
fectamine 2000 (Invitrogen) according to the supplier’s instructions,
and single cell clones were generated by selection in 200 g/ml zeocin
(Invitrogen). To induce expression of SPP and SPPL3, cells were incu-
bated with 1 g/ml doxycycline added to the cell culture medium for
48 h.
Antibodies, Metabolic Labeling, Immunoprecipitation, and Immuno-
blotting—The polyclonal anti-SPP antibody 2812 (against amino acids
201–377 of human SPP) and polyclonal anti-SPPL3 antibody 4a (against
amino acids 370–384 of human SPPL3) were obtained from Memorec
Biotech GmbH (Cologne). The polyclonal anti-SPPL2b antibody N159
was generated by immunization of rabbits with a synthetic peptide rep-
resenting the amino acids 213–227 of human SPPL2b coupled to key-
hole limpet hemocyanin (Eurogentec, Seraing, Belgium). The mono-
clonal anti-Myc antibody 9E10 and the monoclonal anti-LAMP2
antibodywere obtained from the hybridoma bank, themonoclonal anti-
BiP antibody was from Stressgen, and the polyclonal anti-calreticulin
antibody was fromCalbiochem. Pulse-chase experiments, cell lysis, and
immunodetection were carried out as described before (34).
Deglycosylation Experiments—For the deglycosylation experiments
cell lysates were denaturedwith 1% SDS for 10min at 65 °C, diluted 1:10
in assay buffer (50 mM sodium phosphate, pH 7.2, 12 mM EDTA, 0.4%
Nonidet-P40) to a protein concentration of  1 g/l, and treated
overnight at 37 °C with 50 milliunits/ml N-glycosidase F (Roche
Applied Science) or 0.25 milliunits/l endoglycosidase H (Roche
Applied Science).
Immunofluorescence Microscopy—Cells were grown on polylysine-
coated coverslips, fixed for 20 min with phosphate-buffered saline
(PBS), 3.7% paraformaldehyde, permeabilized for 20minwith PBS, 0.2%
Triton X-100, and blocked with PBS, 1% bovine serum albumin. Anti-
body incubations were performed for 1 h at room temperature in phos-
phate-buffered saline followed by incubation with Alexa 488- and Alexa
594-coupled secondary antibodies (Molecular Probes), and mounted









































FIGURE 1. Expression and maturation of SPP and SPPLs. A, lysates of HEK293 cells stably transfected with Myc-tagged SPPL2b (lane 1), SPP (lane 2), or SPPL3 (lane 3) were
immunoprecipitated with antibodies N159, 2812, or 4a, respectively. Immunoprecipitated SPP or SPPLs were identified with the anti-Myc antibody 9E10. Mature and immature forms
of SPPL2b are indicated by arrows. Bands marked with an asterisk (*) represent the putative dimeric forms of the respective protein. Note that tags do not affect expression and
membrane orientation of SPP/SPPL (38). B, HEK293 cells stably expressing SPP and SPPL3 were pulse-labeled with [35S]methionine/cysteine for 15 min and chased for the time points
indicated. Proteins were immunoprecipitated using the 9E10 antibody and detected by autoradiography. Note that neither SPP nor SPPL3 undergoes a molecular weight shift during
the chase period. C, HEK293 cells stably expressing SPPL2b were pulse-labeled with [35S]methionine/cysteine for 15 min and chased for the time points indicated. Proteins were
immunoprecipitated using the 9E10 antibody and detected by autoradiography. Note that SPPL2b undergoes a molecular weight shift during the chase period.
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FishMaintenance and Breeding—Zebrafish weremaintained, mated,
and raised as described (35). Embryos were kept at 28 °C and staged as
described (36). The wild type line AB was used for all experiments.
In Situ Hybridization and Acridine Orange Staining—In situ hybrid-
izations were carried out as described elsewhere (37) with slight modi-
fications. The single-stranded RNA probes were labeled with digoxige-
nin-UTP (Roche Applied Science). The second antibody was
preincubated overnight with zebrafish embryos. All washing steps were
carried out at 65 °C. Washes were as follows: 2 30 min in 50% form-
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FIGURE 2. Posttranslational maturation and endosomal localization of SPPL2b. A, SPPL2b is a glycoprotein that undergoes complex glycosylation. Protein extracts of HEK293
cells stably transfected with SPPL2b were treated with N-glycosidase F (N-Glyc.F) or endoglycosidase H (EndoH). SPPL2b was detected with the anti-Myc antibody 9E10. In untreated
extracts monomeric SPPL2b appears as two bands of 90 and 110 kDa. Whereas treatment with N-glycosidase F shifts both bands completely to a single band of 65 kDa, treatment with
endoglycosidase H causes only a very minor shift of the upper band, suggesting that this species is partially endoglycosidase H-resistant. B, subcellular localization of SPP and SPPLs.
Immunofluorescence microscopy reveals that SPP and SPPL3 colocalize to a large extent with the ER-resident proteins BiP and calreticulin. In contrast, SPPL2b staining shows
significant overlap with LAMP-2, a marker for late endosomes/lysosomes, whereas very little co-localization is observed with BiP. Insets show extensive co-localization of SPPL2b with
LAMP-2-positive vesicles.
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2 SSCT; 2 30 min in 0.2 SSCT. To reduce endogenous phospha-
tase activity, 0.25 mg/ml levamisole was added to the staining buffer.
Dechorionated embryos were incubated alive in 2 mg/ml acridine
orange in E3medium for 30min at room temperature. Stained embryos
were analyzed after 3 wash steps of 5 min with E3 medium.
Antisense gripNAs and Microinjection of Zebrafish Embryos—Anti-
sense gripNAs of 18 nucleotides in length were obtained from Active
Motif. For spp and the sppl genes we used a grip designed against the
ATG-start codon (ATG-grip) to block translational start (the ATG site
is in bold) and an independent gripNA hybridizing to an exon-intron
junction, resulting in a nonsense splicing product (GT-grip). As con-
trols, three bases of the ATG-grip were modified (underlined below). In
the case of spp the ATG control grip is shifted five nucleotides further
upstream in addition to the two modified nucleotides: spp ATG-grip,
5-CTGCTCCACATCCGCCAT-3; spp GT-grip, 5-CGTACCTCA-
TTGTGTGAG-3; spp ATG-control grip, 5-CTACATTCGCCATG-
CTTC-3; sppl2 ATG-grip, 5-TGTGATCTCCCCATCCG-3; sppl2
GT-grip, 5-CTTACTTTTTCCTGTCCC-3; sppl2 ATG-control grip,
5-TATGATCTCGCCATACG-3; sppl3 ATG-grip, 5-CTCTGCTC-
CGCCATGTCA-3; sppl3 GT-grip, 5-CGCACCGTCCATGAGCA-
G-3; sppl3 ATG-control grip, 5-CTCGGCTCCGCAATGCCA-3.
Embryos were microinjected with a Femto JetMicroinjector (Eppen-
dorf) at the one-cell stage with gripNA concentrations varying from
0.12 to 1.0 mM depending on the severity of the observed phenotype.
FIGURE 3. Amino acid sequence alignment of members of the SPP family. A, amino acid sequence alignment of human (h-) SPP/SPPLs and their zebrafish homologues. Black
shading indicates complete conservation in all proteins, and gray shading indicates biochemically similar residues. Dotted lines highlight the predicted active site transmembrane
domains, and the bar highlights the GXGD motif. B, phylogenetic tree based on the neighbor joining algorithm showing the evolutionary distances.
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The injected volume was 2–4 pl. After injection the embryos were
maintained in embryo medium at 28 °C.
Zebrafish cDNA Constructs, mRNA Synthesis, and Generation of
Mutant mRNA—cDNA clones encoding spp (MPMGp637A0723Q2),
sppl2 (MPMGp609O0125Q8), and sppl3 (MPMGp637N1021Q2) were
obtained from the German Resource Centre for Genome Research
(RZPD) (www.rzpd.de). Sequences were submitted to GenBankTM
(accession numbers are AY926458 for spp, AY926457 for sppl2 and
AY926459 for sppl3). Full-length spp, sppl2, and sppl3 were subcloned
into the pCS2 (sitemaker.umich.edu/dlturner.vectors) expression
vector. mRNA was synthesized using the mMESSAGE MACHINE kit
(Ambion) and polyadenylated using a polyadenylation kit (Ambion)
according to the manufacturer’s instructions. The codon encoding the
critical aspartate was mutagenized to an alanine codon after the
QuikChange (Stratagene) protocol. Successfulmutagenesis was verified
by DNA sequencing.
RESULTS
Differential Subcellular Localization of SPPLs—Besides SPP itself, the
SPP family comprises four additional members of unknown function in
mammals, two of which, SPPL2b and SPPL3, are conserved in all verte-
brates ((7, 30); see also Fig. 3). They were, therefore, chosen for a func-
tional analysis in cultured cells and in zebrafish as a model system. As a
first step we examined expression and maturation of Myc-tagged
human SPPL2b (the only SPPL2 present in the zebrafish genome; see
Fig. 3) and SPPL3 in comparison to SPP in HEK293 cells. Clones stably
expressing SPP/SPPLs were generated, and expression levels were ana-
lyzed (Fig. 1A). As shown previously, two major SPP bands were
detected, which may represent monomeric and dimeric variants (28,
38). SPPL2b was expressed as two bands of 90 and 110 kDa (Fig. 1A),
molecular masses considerably higher than predicted (64.7 kDa). In
addition, a higher molecular mass band was also observed, again sug-
gesting oligomerization to a variable degree (Fig. 1A (38)). SPPL3 was
observed as an 40-kDa protein (Fig. 1A). As for SPP and SPPL2b,
dimers and higher molecular mass oligomers of SPPL3 were sometimes
observed (see also Fig. 1B; lower panel).
To investigate whether the two immunoreactive bands of SPPL2b
result from posttranslational modification, pulse-chase experiments
were performed. Whereas SPP and SPPL3 showed no posttranslational
maturation (as monitored by the absence of a molecular mass shift
during the chase period; Fig. 1B), SPPL2b is expressed at time point 0
min as a single band, which during the chase period is reduced at the
expense of a higher molecular mass protein (Fig. 1C). This may suggest
that SPPL2b posttranslationally maturates by glycosylation during its
targeting through the secretory pathway. Putative glycosylation of
SPPL2b was, therefore, further investigated by selective removal of
N-linked sugar side chains (Fig. 2A). N-Glycosidase F treatment of cell
lysates fromSPPL2b-expressing cells resulted in the detection of a single
band of 70 kDa, which roughly corresponds to the calculated molec-
















FIGURE 4. Expression profiles of spp, sppl2, and sppl3 during early zebrafish development and somitogenesis revealed by whole mount in situ hybridization. Ubiquitous
expression of sppl2 and sppl3 at the eight-cell and shield stage is observed (B, C, E, and F). spp, although maternally inherited (as detected by reverse transcription-PCR; M), is not
detectable in these stages by in situ hybridization (A and D). Ubiquitous expression of all three genes at the tail-bud stage (G, H, and I). At the 20-somite stage expression of spp and
sppl3 becomes largely restricted to the central nervous system (J and L), whereas sppl2 expression remains ubiquitous (K). L, the additional signal of sppl3 transcripts in the epiphysis
(white arrow) and somites (som) (black arrow). M, analysis of early expression of spp by reverse transcription-PCR. d1, day 1; neg. control, negative control. Embryos are shown in lateral
view; D–I, ventral to the left; J–L, anterior to the left.
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ment caused only a minor shift of the upper band to a lower molecular
mass (Fig. 2A), whereas the lower molecular weight variant of SPPL2b
was fully endoglycosidase H-sensitive (Fig. 2A). This demonstrates that
the upper band of SPPL2b becomes partially endoglycosidase H-resist-
ant (as observed for example for nicastrin (39–41)) and strongly sug-
gests passage through the Golgi apparatus. This is somewhat surprising
since proteins of the SPP family may have been expected to be located
within early secretory compartments, namely the ER, where signal pep-
tide cleavage occurs (7, 42). Accordingly, SPP even appears to be actively
retained within the ER by a KKXX ER retrieval signal (7).
To further substantiate trafficking of SPPL2b through the secretory
pathway, an indirect immunofluorescence analysis was performed. As
expected (7) SPP co-localized with the ER marker BiP (Fig. 2B). In cells
overexpressing SPPL3, a similar staining pattern was observed that
again overlapped with an ER marker (Fig. 2B), suggesting that SPPL3
also localizes to the ER. In contrast, SPPL2bwas found predominantly in
vesicular structures, whichwere positive for LAMP-2 (Fig. 2B), amarker
for late endosomes/lysosomes (43). Co-staining with the ERmarker BiP
showed little co-localization, demonstrating that SPPL2b does not
accumulatewithin the ER (Fig. 2B). The small amounts of SPPL2b found
in the ER may be due to immature SPPL2b transported through the
early secretory pathway. Thus, the data from indirect immunofluores-
cence are consistent with our observation from the pulse-chase and
deglycosylation experiments (Figs. 1, B and C and 2A) and demonstrate
that SPPL2b, in contrast to SPP and SPPL3, is targeted through the
entire secretory pathway to endosomes/lysosomes. These data demon-
strate that not all proteins of the SPP family are restricted to the early
secretory compartment, indicating functional diversity.
Identification andDevelopmental Expression of Zebrafish SPPLs—To
investigate putative individual proteolytic functions of SPPLs in vivo, we
turned to zebrafish as a model system. We have used this system previ-
ously to study -secretase function in vivo and to elucidate the function
of the Nicastrin-like protein Nicalin (44–46). Sequence comparison
of zebrafish spp and sppls revealed a significant homology to the
human counterparts (Fig. 3A). Interestingly, we found only one sppl2
homologue within the zebrafish genome, which shares highest
sequence identity with SPPL2b (66% compared with 50% with
SPPL2a and 45% with SPPL2c (Fig. 3, A and B)). We refer to this gene
as sppl2 for the remainder of the manuscript (according to the
Zebrafish Nomenclature Committee).
To gain first insight into spp and sppl function, we visualized mRNA
localization by whole mount in situ hybridization during development.
Significant amounts of sppl2 and sppl3mRNAs were detectable before
zygotic transcription at the eight-cell stage, revealing maternal inherit-
ance (Fig. 4,B and C). sppl2 and sppl3 are ubiquitously expressed until
tail-bud stage (Fig. 4,H and I). Transcripts of spp became first detectable
by whole mount in situ hybridization at tail-bud stage (Fig. 4G). How-
ever, we expected spp to also be expressed early during development
since SPP has been shown to clear signal peptides (7), a process most
likely required at all stages of development. Analysis of early stage
embryos by a more sensitive reverse transcription-PCR approach
revealed the expected maternal inheritance of spp and expression at all
stages analyzed (Fig. 4M). Transcripts of spp, sppl2, and sppl3 are ubiq-
uitously expressed at the five-somite stage (data not shown). From the
20-somite stage onward, expression of spp and sppl3 becomes restricted
to the central nervous system, whereas sppl2 appears to be more ubiq-
uitously expressed (Fig. 4, J–L). sppl3 transcripts are additionally
detected in the epiphysis and in somites at the 20-somite stage (Fig. 4L).
All spp and sppl transcripts are continuously expressed throughout the
brain from day 1 until day 3 post-fertilization (data not shown).
Knockdown of Zebrafish spp and sppl—To gain further insight into
the in vivo function of spp family members, we transiently knocked
TABLE ONE
Phenotypic effects of knockdown and loss-of-function variants of spp/sppl
p value is derived from 2 test against the control group, wt, wild type.
spp Concentration n Neuronaldegeneration No phenotype Unspecific p
% % %
spp ATG-grip 0.12 mM 97 85 14 1 0.0001
spp GT-grip 1 mM 117 70 28 2 0.0001
spp ATG-control grip 1 mM 47 0 94 6
spp D268A capped mRNA 0.75 M 110 26 66 7 0.0193
spp wt capped mRNA 1 M 39 5 85 10
sppl2 Concentration n Blood clot No phenotype Unspecific p
% % %
sppl2 ATG-grip 1 mM 188 76 22 4 0.0001
sppl2 GT-grip 1 mM 205 86 10 4 0.0001
sppl2 ATG-control grip 1 mM 121 4 95 1
sppl2 GT-grip 0.75 mM 142 86 8 5
sppl2 GT-grip  sppl2 wt mRNA 0.75 mM  0.36 M 119 41 54 5 0.0001
sppl2 D422A mRNA 0.36 M 123 49 43 8 0.0001
sppl2 wt mRNA 0.36 M 49 0 96 4
sppl3 Concentration n Neuronaldegeneration No phenotype Unspecific p
% % %
sppl3 ATG-grip 0.5 mM 269 84 14 2 0.0001
sppl3 GT-grip 0.5 mM 148 70 27 3 0.0001
sppl3 ATG-control grip 0.5 mM 53 0 96 4
sppl3 D272A mRNA 0.63M 159 48 45 7 0.0001
sppl3 wt mRNA 0.63M 31 0 94 6
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down spp and sppls by injection of antisense gripNAs into one-cell
stage zebrafish embryos. Injection of a gripNA targeting the start
codon of spp (referred to as spp ATG-grip) led to a cell death phe-
notype within the nervous system (85% of cases, n  97; TABLE
ONE; Fig. 5, B and B). An indistinguishable phenotype was obtained
by injection of a sppl3ATG-grip (84% of cases, n 269) (Fig. 5,D and
D). In contrast, knockdown of sppl2 by injection of a sppl2 ATG-
grip resulted in a distinct phenotype with an enlarged caudal vein
accumulating blood (76% of the cases; n  188) (Fig. 5, C and C). To
rule out defects in endothelial and hematopoietic differentiation,
several in situ markers were tested (flt4, krox20, scl, ephB4, flk1,
gata1). None of these markers revealed differences compared with
uninjected control embryos (data not shown).
To demonstrate the cell death phenotype in spp and sppl3 knock-
down embryos more directly, we used the cell death marker acridine
orange (47). Staining of non-injected embryos did not show cell
labeling above background levels (Fig. 6A). In contrast, staining of
spp-grip- and sppl3-grip-injected embryos resulted in the massive
labeling of cells in the brain and the spinal cord (Fig. 6, B and D). In
both cases we observed a range of phenotypes of different strength.
Figs. 5, B and D, show more strongly affected embryos, demonstrat-
ing pronounced cell death. We selected less severely affected
embryos for Figs. 5, B and D, and 6 to visualize individual dying
cells. Acridine orange staining of sppl2 knockdown embryos did not
result in significant cell labeling, demonstrating the absence of cell
death (Fig. 6C).
FIGURE 5. Loss-of-function phenotypes of spp and sppl in zebrafish. Uninjected embryo at 24 h post-fertilization (A) showing the normal midbrain-hindbrain boundary (A, white
arrow) and a wild type (wt) caudal vein (A, arrowheads). Knockdown (KD) of spp (ATG-grip) results in cell death within the nervous system (B and B). Dead cells are visible in the
midbrain and are clearly distinguishable by their round morphology (black arrows in B and B). Overexpression of spp D268A mRNA phenocopies the spp knockdown phenotype (B).
Embryos injected with sppl2 ATG-grip show erythrocyte accumulation in the enlarged caudal vein (arrowheads in C). Embryos injected with sppl2 D422A mRNA show the sppl2
knockdown phenotype (C). Injection of sppl3 ATG-grip results in broad cell death within the nervous system (D and D). Dead cells are present throughout the central nervous system
(black arrows in D and D). Overexpression of sppl3 D272 mRNA phenocopies the sppl3 knockdown phenotype (D). White arrows mark the midbrain-hindbrain boundary. All embryos
are oriented with anterior to the left and posterior to the right. Higher power views in B, B, D, and D show less severely affected embryos compared with embryos shown in
B and D.
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A number of control experiments were performed to demonstrate
the specificity of the observed phenotypes. Injection of control gripNAs
did not lead to significant defects (TABLE ONE). Moreover, the indi-
vidual phenotypes were reproduced by injection of independent grip-
NAs targeting splice donor sites of spp, sppl2, and sppl3 transcripts
(referred to as GT-grips; TABLE ONE). The sppl2 GT-grip-induced
knockdown phenotype could additionally be rescued by coinjection of
wild type sppl2 mRNA. The percentage of embryos showing a pheno-
type could be significantly reduced from 86% (n 142) to 41% (n 119)
(TABLE ONE), again demonstrating its specificity. Taken together, we
have generated knockdown phenotypes of spp and sppl by two inde-
pendent gripNAs, targeting the start codons and splice donor sites,
revealing distinct phenotypes for sppl2 and spp/sppl3.
Overexpression of Dominant Negative Mutants Phenocopies the
Knockdown Defects—We next wanted to analyze if the observed spp
knockdown phenotype can be correlated to its catalytic function. One
possibility to examine this is the expression of loss-of-functionmutants.
Weihofen et al. (7) have shown that mutagenesis of the aspartate within
the GXGD motif (Asp-265 in human SPP) to alanine abolishes proteo-
lytic activity of SPP.We, therefore, generated the correspondingD268A
mutation in spp and injected the mRNA into one-cell stage embryos.
This resulted in a neuronal cell death phenotype very similar to that seen
in the spp knockdown embryos (Fig. 5, compare B and B; TABLE
ONE). Thus, the observed knockdown phenotype is not only specific
but is most likely caused by a loss of spp activity. Like SPP, all members
of the SPPL family contain a GXGD motif at the corresponding posi-
tions of their transmembrane domains (Fig. 3A) and might, therefore,
also represent GXGD type aspartyl proteases. Analogous to SPP, we
therefore mutagenized the corresponding aspartates to alanine and
injected the mutant mRNAs into one-cell stage embryos. sppl2 D422A
mRNA injection led to blood clots in 49% of cases (n  123) (Fig. 5,
compare C and C), whereas injection of wild type sppl2mRNA of the
same concentration did not cause any phenotype (TABLE ONE). Sim-
ilarly, injection of sppl3 D272A mRNA but not wild type mRNA phe-
nocopied the sppl3 knockdown phenotype in 48% of the injected
embryos (n  159) (Fig. 5, compare D and D) (TABLE ONE). Taken
together, these data confirm the corresponding knockdown phenotypes
and suggest that sppl2 and sppl3 are also likely to function as aspartyl
proteases of the GXGD type.
DISCUSSION
Upon the identification of SPP, data base searches revealed a family of
SPP homologues, the SPPLs/PSHs (7, 30). However, it remained
unknown whether these proteins are proteolytically active and whether
they are functionally redundant to SPP. We have addressed these ques-
tions by studying the biochemical and functional properties of SPPL2b
and SPPL3 in comparison to SPP. Already the analysis of their subcel-
lular localization in cultured cells by indirect immunofluorescence,
pulse-chase, and deglycosylation experiments revealed striking differ-
ences.Whereas SPPL3, like SPP, localizes to the ER, SPPL2b is predom-
inantly found in endosomes/lysosomes. This by itself may already sug-
gest a non-redundant function of SPPL2b. To test this hypothesis, we
used the zebrafish as amodel system for a functional characterization of
SPP and SPPLs in vivo. Analysis of their expression patterns during
embryogenesis and the phenotypes caused by antisense-mediated
knockdown also revealed similarities between SPP and SPPL3. Both are
strongly expressed in the nervous system, and their knockdown appears
to cause neuronal degeneration. In contrast, SPPL2b is expressed more
ubiquitously, and its knockdown results in an enlarged caudal veinwith-
out any detectable cell death. These results demonstrate that SPP and
SPPLs have important functions during zebrafish embryogenesis.
Moreover, they are in agreement with our cell culture data and suggest
functional redundancy between SPP and SPPL3. SPPL2b, however,
appears to have a role distinct from the other family members.
We then asked the question of whether the knockdown phenotypes
are caused by a loss of proteolytic activity. One possibility to address this
is the analysis of dominant negative mutants. For SPP, mutagenesis of
the aspartate within the GXGD motif to alanine (D265A) has been
shown to cause loss of enzymatic activity (7). We, therefore, tested the
effect of the corresponding mutation in zebrafish spp (D268A) and
found that its overexpression in zebrafish embryos results in a pheno-
copy of the spp knockdown phenotype. This suggested that active site
mutations in SPP act in a dominant negative manner. Importantly, the
corresponding mutations in the GXGD motifs of sppl2 and sppl3 also
caused a phenocopy of the respective knockdown phenotypes, indicat-
ing that they represent active site mutations as well. These data led us to
conclude that SPPL2b and SPPL3 are likely to represent activemembers
of the SPP protease family. Moreover, we suggest that SPPL2b is an
endosomal GXGD type aspartyl protease, which exerts a function dis-
tinct from the ER-located SPP and SPPL3.
Deficiency of the Caenorhabditis elegans imp-2 gene, which corre-
sponds to vertebrate SPP, also caused a severe developmental pheno-
type, which could be mimicked by reduced cholesterol concentrations
or the disruption of Ce-Irp-1 (48). Ce-Irp-1 is a homologue of the ver-









FIGURE 6. Cell death in spp and sppl3 loss-of-function phenotypes. Acridine orange
stains dying cells. In wild type (wt) embryos only a few dying cells are seen at 24 h
post-fertilization (A). In spp knockdown (KD) embryos (GT-grip) dead cells are seen evenly
distributed throughout the central nervous system and spinal cord (B). sppl2 knockdown
embryos (GT-grip) do not show significantly elevated cell death compared with wild
type embryos (C). sppl3 knockdown embryos (ATG-grip) show cell death throughout the
brain (D). The white rectangles mark the areas of the higher power magnifications shown
on the right. In B and D less severely affected embryos are shown to allow visualization of
individual cells. Autofluorescence of the yolk is observed in A–D.
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with lipoprotein receptor-related proteins appears to result in neurode-
generation in mice (49), a phenotype also observed upon down-regula-
tion of spp in zebrafish.
Based on the severity of the observed phenotypes, all investigated
SPPLs appear to have important biological functions throughout devel-
opment. This is supported by their maternal inheritance and rather
ubiquitous expression. However, in the absence of specific substrates
for SPPLs, one can only speculate about the physiological functions of
SPPLs. The endosomal/lysosomal localization of SPPL2b suggests that
it may be involved in removal of signal peptides, which escaped SPP-
mediated cleavage within the ER. However, the loss-of-function pheno-
types may suggest additional, more essential functions for SPPL2b.
These may include generation of bioactive signaling peptides, as has
been observed for SPP (7). One may even assume that intracellular
cytoplasmic domains of type II transmembrane proteins may be
released upon reinternalization of the substrate from the plasma
membrane.
Taken together, proteolysis by GXGD-type aspartyl proteases within
or close to themembrane indeed appears to be an “increasing scheme of
variation” (24), which during evolution was fine-tuned to allow a regu-
lated release of a variety of important signaling molecules by a number
of different proteases. In addition to these essential signaling functions,
some members of the SPP family may also be required to remove pro-
teolytically generated small peptides located within the membrane of
the ER or endosomes/lysosomes. A similar rather general degradation
activity may also be provided by -secretase. However, this activity may
be selective to small intramembrane stubs of type I proteins, whereas
SPPs (2) and probably SPPLs as well may selectively remove proteolyti-
cally generated stubs in a type II membrane orientation.
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